Disclosure Panels Details Page
B-Cell Lymphomas Panel - Disclosures as of 05/09/2018
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Jeremy Abramson MD, MMSc | None | Amgen Inc. Celgene Corporation Gilead Sciences, Inc. Juno Therapeutics, Inc. Karyopharm Therapeutics Merck & Co., Inc. Novartis Pharmaceuticals Corporation Seattle Genetics, Inc. Verastem |
None | None | ✔ |
| Ranjana Advani MD | None | AstraZeneca Pharmaceuticals LP Autolus Bayer HealthCare Cell Medica Genentech, Inc. Gilead Kite Pharma Seattle Genetics Takeda |
None | None | ✔ |
| Babis Andreadis MD, MSCE | Amgen Inc. Cellerant GlaxoSmithKline Incyte juno Novartis Pharmaceuticals Corporation Pharmacyclics |
Astellas Pharma US, Inc. Bayer HealthCare Celgene Corporation Genentech, Inc. Gilead Novartis Pharmaceuticals Corporation Seatlle Genetics |
None | None | ✔ |
| Nancy Bartlett MD | None | Pfizer Inc. | None | None | ✔ |
| Paolo Caimi MD | Genentech, Inc. Millennium Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc. Roche Laboratories, Inc. |
Kite Pharma | Celgene Corporation | Cellectis SA|Concert Pharma | - |
| Julie Chang MD | Adaptive Biotechnologies Celgene Corporation Genentech, Inc. |
None | None | None | - |
| Julio Chavez MD | None | Incyte | AbbVie, Inc. Janssen Pharmaceutica Products, LP |
None | ✔ |
| Beth Christian MD | Acerta Pharma Bristol-Myers Squibb Company Celgene Corporation Genentech, Inc. Immunomedics, Inc. Janssen Pharmaceutica Products, LP Merck & Co., Inc. Millennium Pharmaceuticals, Inc. MorphoSys AG Pharmacyclics Roche Laboratories, Inc. Seattle Genetics, Inc. Teva Pharmaceutical Industries Ltd |
None | None | None | ✔ |
| Sarah DeVincenzo PharmD, BCPS | None | Decision Resources Group Consulting | None | None | - |
| Mary Dwyer MS | None | None | None | None | ✔ |
| Luis Fayad MD | None | None | None | None | - |
| Martha Glenn MD | Amgen Inc. | None | None | None | - |
| Leo Gordon MD | Janssen Pharmaceutica Products, LP | Takeda Pharmaceuticals North America, Inc. | None | None | ✔ |
| Kristina Gregory MSN, RN, OCN | None | None | None | None | ✔ |
| Thomas Habermann MD | None | Celgene Corporation Genentech, Inc. Roche Laboratories, Inc. |
None | None | ✔ |
| Evelyn Handel PharmD, BCOP, BCPS | None | None | None | None | ✔ |
| Laura Hanisch PsyD | None | None | None | None | - |
| Nancy Lee Harris MD | None | None | None | None | - |
| Francisco Hernandez-Ilizaliturri MD | None | Celgene Corporation Seattle Genetics |
Pharmacyclics | None | ✔ |
| Mark Kaminski MD | Millennium Pharmaceuticals, Inc. | Nordic Nanovector | None | None | ✔ |
| Ann Karosas RPh, BCOP | None | None | None | None | ✔ |
| Christopher Kelsey MD | None | None | None | None | ✔ |
| Nadia Khan MD | Bristol-Myers Squibb Company Fox Chase Cancer Center |
None | Genentech, Inc. | None | ✔ |
| Susan Krivacic MPAff | None | None | None | None | ✔ |
| Ann LaCasce MD, MMSc | Bristol-Myers Squibb Company Celgene Corporation Forty seven Seattle Genetics |
Forty Seven | None | None | ✔ |
| Joan McClure MS | None | None | None | None | ✔ |
| Amitkumar Mehta MD | AstraZeneca Pharmaceuticals LP | None | Aileron Bristol-Myers Squibb Company Gilead Sciences Kite Pharmaceuticals |
None | ✔ |
| Auayporn Nademanee MD | None | None | None | None | ✔ |
| Donna Powell DHSc, CMD, RT(T) | None | None | None | None | - |
| Rachel Rabinovitch MD | None | None | None | None | - |
| Nishitha Reddy MD | None | AbbVie, Inc. Celgene Corporation |
Gilead | Bristol-Myers Squibb Company | ✔ |
| Erin Reid MD | AbbVie, Inc. ADC Therapeutics AIDS Malignancy Consortium CALGB/CTSU Janssen Pharmaceutica Products, LP Millennium Pharmaceuticals, Inc. Pharmacyclics Takeda Pharmaceuticals North America, Inc. |
None | None | None | - |
| Kenneth Roberts MD | None | None | None | None | - |
| Jack Skinner PhD | None | None | None | None | - |
| Stephen Smith MD | Acerta Pharma DeNovo Biopharma Genentech, Inc. Merck & Co., Inc. Pharmacyclics Portola Pharmaceuticals, Inc. Seattle Genetics, Inc. |
Merck & Co., Inc. | None | None | ✔ |
| Erin Snyder MD | None | None | None | None | - |
| Hema Sundar PhD | None | None | None | None | ✔ |
| Lode Swinnen MBChB | Johns Hopkins University | None | Genentech, Inc. Pharmacyclics |
None | - |
| Amy Tuten PharmD, BCOP | None | None | None | None | - |
| Julie Vose MD, MBA | None | AbbVie, Inc. Epizyme Janssen Pharmaceutica Products, LP Karyopharm Therapeutics Legend Novartis Pharmaceuticals Corporation Roche Laboratories, Inc. Sandoz vaniam group |
None | None | ✔ |
| Andrew Zelenetz MD, PhD | AbbVie, Inc. BeiGene Genentech, Inc. Gilead MEI Pharmaceuticals |
Adaptive Biotechnology Amgen Inc. Celgene Corporation Genentech, Inc. Gilead Hoffman La Roche MEI Pharma Pfizer Inc. Pharmacyclics Roche Laboratories, Inc. Sandoz Versatem |
None | None | ✔ |